We are pleased to announce the launch of AGU Registry!
The AGU Registry creates a platform for patients around the world to strengthen their voices and share information about Aspartylglucosaminuria (AGU), a disease that leads to developmental, speech/language, and motor delays . Aspartylglucosaminuria (AGU) currently has no cure. Designed with the input of scientists and patients, this global resource will provide data for researchers to use to advance drug development and treatment options to help improve Aspartylglucosaminuria (AGU) patient care. Join now and let your data tell your story! To register, click here.
Read More >